Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
A System for Simple Real-Time Anastomotic Failure Detection and Wireless Blood Flow Monitoring in the Lower Limbs.

IEEE journal of translational engineering in health and medicine

Rothfuss MA, Franconi NG, Unadkat JV, Gimbel ML, Star A, Mickle MH, Sejdic E.
PMID: 27730016
IEEE J Transl Eng Health Med. 2016 Aug 25;4:4100114. doi: 10.1109/JTEHM.2016.2588504. eCollection 2016.

Current totally implantable wireless blood flow monitors are large and cannot operate alongside nearby monitors. To alleviate the problems with the current monitors, we developed a system to monitor blood flow wirelessly, with a simple and easily interpretable real-time...

Cite
Rothfuss MA, Franconi NG, Unadkat JV, et al. A System for Simple Real-Time Anastomotic Failure Detection and Wireless Blood Flow Monitoring in the Lower Limbs. IEEE J Transl Eng Health Med. 2016;4:4100114doi: 10.1109/JTEHM.2016.2588504.
Rothfuss, M. A., Franconi, N. G., Unadkat, J. V., Gimbel, M. L., Star, A., Mickle, M. H., & Sejdic, E. (2016). A System for Simple Real-Time Anastomotic Failure Detection and Wireless Blood Flow Monitoring in the Lower Limbs. IEEE journal of translational engineering in health and medicine, 44100114. https://doi.org/10.1109/JTEHM.2016.2588504
Rothfuss, Michael A, et al. "A System for Simple Real-Time Anastomotic Failure Detection and Wireless Blood Flow Monitoring in the Lower Limbs." IEEE journal of translational engineering in health and medicine vol. 4 (2016): 4100114. doi: https://doi.org/10.1109/JTEHM.2016.2588504
Rothfuss MA, Franconi NG, Unadkat JV, Gimbel ML, Star A, Mickle MH, Sejdic E. A System for Simple Real-Time Anastomotic Failure Detection and Wireless Blood Flow Monitoring in the Lower Limbs. IEEE J Transl Eng Health Med. 2016 Aug 25;4:4100114. doi: 10.1109/JTEHM.2016.2588504. eCollection 2016. PMID: 27730016; PMCID: PMC5052026.
Copy Download .nbib Format: NLM
Taking diabetes services out of hospital into the community.

London journal of primary care

Unadkat N, Evans L, Nasir L, Thomas P, Chandok R.
PMID: 25949676
London J Prim Care (Abingdon). 2012;5(1):87-91. doi: 10.1080/17571472.2013.11493386. Epub 2013 May 28.

We describe four stages of an initiative to co-create a shared care system to treat patients with diabetes out of hospital and in the community.

Cite
Unadkat N, Evans L, Nasir L, et al. Taking diabetes services out of hospital into the community. London J Prim Care (Abingdon). 2013;5(1):87-91doi: 10.1080/17571472.2013.11493386.
Unadkat, N., Evans, L., Nasir, L., Thomas, P., & Chandok, R. (2012). Taking diabetes services out of hospital into the community. London journal of primary care, 5(1), 87-91. https://doi.org/10.1080/17571472.2013.11493386
Unadkat, Neha, et al. "Taking diabetes services out of hospital into the community." London journal of primary care vol. 5,1 (2012): 87-91. doi: https://doi.org/10.1080/17571472.2013.11493386
Unadkat N, Evans L, Nasir L, Thomas P, Chandok R. Taking diabetes services out of hospital into the community. London J Prim Care (Abingdon). 2012;5(1):87-91. doi: 10.1080/17571472.2013.11493386. Epub 2013 May 28. PMID: 25949676; PMCID: PMC4413714.
Copy Download .nbib Format: NLM
More collaboration needed between drug development and imaging communities.

Drug discovery today

Mankoff DA, Link JM, Unadkat J, Eary JF, Krohn KA.
PMID: 11369289
Drug Discov Today. 2001 May 01;6(10):514-515. doi: 10.1016/s1359-6446(01)01801-3.

No abstract available.

Cite
Mankoff DA, Link JM, Unadkat J, et al. More collaboration needed between drug development and imaging communities. Drug Discov Today. 2001;6(10):514-515doi: 10.1016/s1359-6446(01)01801-3.
Mankoff, D. A., Link, J. M., Unadkat, J., Eary, J. F., & Krohn, K. A. (2001). More collaboration needed between drug development and imaging communities. Drug discovery today, 6(10), 514-515. https://doi.org/10.1016/s1359-6446(01)01801-3
Mankoff, D A., et al. "More collaboration needed between drug development and imaging communities." Drug discovery today vol. 6,10 (2001): 514-515. doi: https://doi.org/10.1016/s1359-6446(01)01801-3
Mankoff DA, Link JM, Unadkat J, Eary JF, Krohn KA. More collaboration needed between drug development and imaging communities. Drug Discov Today. 2001 May 01;6(10):514-515. doi: 10.1016/s1359-6446(01)01801-3. PMID: 11369289.
Copy Download .nbib Format: NLM
Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters.

International journal of proteomics

Prasad B, Unadkat JD.
PMID: 24719762
Int J Proteomics. 2014;2014:451510. doi: 10.1155/2014/451510. Epub 2014 Feb 25.

We studied the precision of quantification of organic anion-transporting polypeptide 1B1 (OATP1B1), OATP1B3, OATP2B1, and P-glycoprotein (P-gp) in human livers by surrogate peptide based LC-MS/MS approach using two different internal standards: stable isotope labeled peptide (SIL) versus stable isotope...

Cite
Prasad B, Unadkat JD. Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters. Int J Proteomics. 2014;2014:451510doi: 10.1155/2014/451510.
Prasad, B., & Unadkat, J. D. (2014). Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters. International journal of proteomics, 2014451510. https://doi.org/10.1155/2014/451510
Prasad, Bhagwat, and Unadkat, Jashvant D. "Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters." International journal of proteomics vol. 2014 (2014): 451510. doi: https://doi.org/10.1155/2014/451510
Prasad B, Unadkat JD. Comparison of Heavy Labeled (SIL) Peptide versus SILAC Protein Internal Standards for LC-MS/MS Quantification of Hepatic Drug Transporters. Int J Proteomics. 2014;2014:451510. doi: 10.1155/2014/451510. Epub 2014 Feb 25. PMID: 24719762; PMCID: PMC3955635.
Copy Download .nbib Format: NLM
Paediatric aneurysmal bone cyst: not as easy as ABC.

Journal of surgical case reports

Unadkat S, Adams A, Richards P, Bajaj Y.
PMID: 29423170
J Surg Case Rep. 2018 Feb 02;2018(2):rjy008. doi: 10.1093/jscr/rjy008. eCollection 2018 Feb.

Aneurysmal bone cysts (ABCs) are expansile cystic lesions that can affect any bone of the body. Whilst these lesions are histologically benign, the lesions are locally aggressive and can affect the integrity of the affected bone as well as...

Cite
Unadkat S, Adams A, Richards P, et al. Paediatric aneurysmal bone cyst: not as easy as ABC. J Surg Case Rep. 2018;2018(2):rjy008doi: 10.1093/jscr/rjy008.
Unadkat, S., Adams, A., Richards, P., & Bajaj, Y. (2018). Paediatric aneurysmal bone cyst: not as easy as ABC. Journal of surgical case reports, 2018(2), rjy008. https://doi.org/10.1093/jscr/rjy008
Unadkat, Samit, et al. "Paediatric aneurysmal bone cyst: not as easy as ABC." Journal of surgical case reports vol. 2018,2 (2018): rjy008. doi: https://doi.org/10.1093/jscr/rjy008
Unadkat S, Adams A, Richards P, Bajaj Y. Paediatric aneurysmal bone cyst: not as easy as ABC. J Surg Case Rep. 2018 Feb 02;2018(2):rjy008. doi: 10.1093/jscr/rjy008. eCollection 2018 Feb. PMID: 29423170; PMCID: PMC5798087.
Copy Download .nbib Format: NLM
Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome.

CPT: pharmacometrics & systems pharmacology

Anoshchenko O, Milad MA, Unadkat JD.
PMID: 34273255
CPT Pharmacometrics Syst Pharmacol. 2021 Sep;10(9):1057-1070. doi: 10.1002/psp4.12674. Epub 2021 Jul 23.

We have previously developed a maternal-fetal physiologically-based pharmacokinetic (m-f PBPK) model to dynamically predict (and verify) fetal-maternal exposure to drugs that passively diffuse across the placenta. Here, we extended the application of this model to dynamically predict fetal exposure...

Cite
Anoshchenko O, Milad MA, Unadkat JD. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. CPT Pharmacometrics Syst Pharmacol. 2021;10(9):1057-1070doi: 10.1002/psp4.12674.
Anoshchenko, O., Milad, M. A., & Unadkat, J. D. (2021). Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. CPT: pharmacometrics & systems pharmacology, 10(9), 1057-1070. https://doi.org/10.1002/psp4.12674
Anoshchenko, Olena, et al. "Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome." CPT: pharmacometrics & systems pharmacology vol. 10,9 (2021): 1057-1070. doi: https://doi.org/10.1002/psp4.12674
Anoshchenko O, Milad MA, Unadkat JD. Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome. CPT Pharmacometrics Syst Pharmacol. 2021 Sep;10(9):1057-1070. doi: 10.1002/psp4.12674. Epub 2021 Jul 23. PMID: 34273255; PMCID: PMC8452292.
Copy Download .nbib Format: NLM
Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2).

Drug metabolism and disposition: the biological fate of chemicals

Chen X, Unadkat JD, Mao Q.
PMID: 34326138
Drug Metab Dispos. 2021 Oct;49(10):910-918. doi: 10.1124/dmd.121.000505. Epub 2021 Jul 29.

(-)-Δ

Cite
Chen X, Unadkat JD, Mao Q. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Drug Metab Dispos. 2021;49(10):910-918doi: 10.1124/dmd.121.000505.
Chen, X., Unadkat, J. D., & Mao, Q. (2021). Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Drug metabolism and disposition: the biological fate of chemicals, 49(10), 910-918. https://doi.org/10.1124/dmd.121.000505
Chen, Xin, et al. "Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2)." Drug metabolism and disposition: the biological fate of chemicals vol. 49,10 (2021): 910-918. doi: https://doi.org/10.1124/dmd.121.000505
Chen X, Unadkat JD, Mao Q. Tetrahydrocannabinol and Its Major Metabolites Are Not (or Are Poor) Substrates or Inhibitors of Human P-Glycoprotein [ATP-Binding Cassette (ABC) B1] and Breast Cancer Resistance Protein (ABCG2). Drug Metab Dispos. 2021 Oct;49(10):910-918. doi: 10.1124/dmd.121.000505. Epub 2021 Jul 29. PMID: 34326138; PMCID: PMC8626638.
Copy Download .nbib Format: NLM
Doctors' wellbeing: self-care during the covid-19 pandemic.

BMJ (Clinical research ed.)

Unadkat S, Farquhar M.
PMID: 32209559
BMJ. 2020 Mar 24;368:m1150. doi: 10.1136/bmj.m1150.

No abstract available.

Cite
Unadkat S, Farquhar M. Doctors' wellbeing: self-care during the covid-19 pandemic. BMJ. 2020;368:m1150doi: 10.1136/bmj.m1150.
Unadkat, S., & Farquhar, M. (2020). Doctors' wellbeing: self-care during the covid-19 pandemic. BMJ (Clinical research ed.), 368m1150. https://doi.org/10.1136/bmj.m1150
Unadkat, Shreena, and Farquhar, Michael. "Doctors' wellbeing: self-care during the covid-19 pandemic." BMJ (Clinical research ed.) vol. 368 (2020): m1150. doi: https://doi.org/10.1136/bmj.m1150
Unadkat S, Farquhar M. Doctors' wellbeing: self-care during the covid-19 pandemic. BMJ. 2020 Mar 24;368:m1150. doi: 10.1136/bmj.m1150. PMID: 32209559.
Copy Download .nbib Format: NLM
A Unilateral Mucoperichondrial/Mucoperiosteal Flap Including Inferior Turbinate with Contralateral Underlay Xenograft for a Large Nasal Septal Perforation Repair.

Facial plastic surgery & aesthetic medicine

Pendolino AL, Jaafar M, Unadkat S, Zhang H, Randhawa P, Andrews PJ.
PMID: 32456462
Facial Plast Surg Aesthet Med. 2020 May 22; doi: 10.1089/fpsam.2020.0022. Epub 2020 May 22.

No abstract available.

Cite
Pendolino AL, Jaafar M, Unadkat S, et al. A Unilateral Mucoperichondrial/Mucoperiosteal Flap Including Inferior Turbinate with Contralateral Underlay Xenograft for a Large Nasal Septal Perforation Repair. Facial Plast Surg Aesthet Med. 2020;doi: 10.1089/fpsam.2020.0022.
Pendolino, A. L., Jaafar, M., Unadkat, S., Zhang, H., Randhawa, P., & Andrews, P. J. (2020). A Unilateral Mucoperichondrial/Mucoperiosteal Flap Including Inferior Turbinate with Contralateral Underlay Xenograft for a Large Nasal Septal Perforation Repair. Facial plastic surgery & aesthetic medicine, . https://doi.org/10.1089/fpsam.2020.0022
Pendolino, Alfonso Luca, et al. "A Unilateral Mucoperichondrial/Mucoperiosteal Flap Including Inferior Turbinate with Contralateral Underlay Xenograft for a Large Nasal Septal Perforation Repair." Facial plastic surgery & aesthetic medicine vol. (2020). doi: https://doi.org/10.1089/fpsam.2020.0022
Pendolino AL, Jaafar M, Unadkat S, Zhang H, Randhawa P, Andrews PJ. A Unilateral Mucoperichondrial/Mucoperiosteal Flap Including Inferior Turbinate with Contralateral Underlay Xenograft for a Large Nasal Septal Perforation Repair. Facial Plast Surg Aesthet Med. 2020 May 22; doi: 10.1089/fpsam.2020.0022. Epub 2020 May 22. PMID: 32456462.
Copy Download .nbib Format: NLM
Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer.

Urology

Unadkat P, Fleishman A, Olumi AF, Wagner A, Chang P, Kim SP, Korets R, Gershman B.
PMID: 33636210
Urology. 2021 Jul;153:221-227. doi: 10.1016/j.urology.2021.02.019. Epub 2021 Feb 24.

OBJECTIVE: To (1) examine the contemporary incidence of occult inguinal LN metastases and (2) identify predictors of occult inguinal LN metastases to improve selection of cN0 patients for inguinal lymphadenectomy (ILND).METHODS: We identified 590 men with cTany cN0 cM0...

Cite
Unadkat P, Fleishman A, Olumi AF, et al. Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer. Urology. 2021;153:221-227doi: 10.1016/j.urology.2021.02.019.
Unadkat, P., Fleishman, A., Olumi, A. F., Wagner, A., Chang, P., Kim, S. P., Korets, R., & Gershman, B. (2021). Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer. Urology, 153221-227. https://doi.org/10.1016/j.urology.2021.02.019
Unadkat, Pooja, et al. "Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer." Urology vol. 153 (2021): 221-227. doi: https://doi.org/10.1016/j.urology.2021.02.019
Unadkat P, Fleishman A, Olumi AF, Wagner A, Chang P, Kim SP, Korets R, Gershman B. Contemporary Incidence and Predictors of Occult Inguinal Lymph Node Metastases in Men With Clinically Node-negative (cN0) Penile Cancer. Urology. 2021 Jul;153:221-227. doi: 10.1016/j.urology.2021.02.019. Epub 2021 Feb 24. PMID: 33636210.
Copy Download .nbib Format: NLM
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

European journal of cancer (Oxford, England : 1990)

Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, Kaur RP, Zhao T, Ramanathan M, Schartinger VH, Emanuel O, Helman S, Varghese J, Dudas J, Riechelmann H, Sprung S, Haybaeck J, Howard D, Engel NW, Stewart S, Brooks L, Pickles JC, Jacques TS, Fenton TR, Williams L, Vaz FM, O'Flynn P, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Royle G, Franchi A, Maragliano R, Battocchio S, Bewicke-Copley H, Pipinikas C, Webster A, Thirlwell C, Ho D, Teschendorff A, Zhu T, Steele CD, Pillay N, Vanhaesebroeck B, Mohyeldin A, Fernandez-Miranda J, Park KW, Le QT, West RB, Saade R, Manes RP, Omay SB, Vining EM, Judson BL, Yarbrough WG, Sansovini M, Silvia N, Grassi I, Bongiovanni A, Capper D, Schüller U, Thavaraj S, Sandison A, Surda P, Hopkins C, Ferrari M, Mattavelli D, Rampinelli V, Facchetti F, Nicolai P, Bossi P, Henriquez OA, Magliocca K, Solares CA, Wise SK, Llorente JL, Patel ZM, Nayak JV, Hwang PH, Lacy PD, Woods R, O'Neill JP, Jay A, Carnell D, Forster MD, Ishii M, London NR, Bell DM, Gallia GL, Castelnuovo P, Severi S, Lund VJ, Hanna EY.
PMID: 34980502
Eur J Cancer. 2021 Dec 31; doi: 10.1016/j.ejca.2021.09.046. Epub 2021 Dec 31.

INTRODUCTION: Olfactory neuroblastoma (ONB) is a rare cancer of the sinonasal region. We provide a comprehensive analysis of this malignancy with molecular and clinical trial data on a subset of our cohort to report on the potential efficacy of...

Cite
Lechner M, Takahashi Y, Turri-Zanoni M, et al. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer. 2021;doi: 10.1016/j.ejca.2021.09.046.
Lechner, M., Takahashi, Y., Turri-Zanoni, M., Liu, J., Counsell, N., Hermsen, M., Kaur, R. P., Zhao, T., Ramanathan, M., Schartinger, V. H., Emanuel, O., Helman, S., Varghese, J., Dudas, J., Riechelmann, H., Sprung, S., Haybaeck, J., Howard, D., Engel, N. W., Stewart, S., Brooks, L., Pickles, J. C., Jacques, T. S., Fenton, T. R., Williams, L., Vaz, F. M., O'Flynn, P., Stimpson, P., Wang, S., Hannan, S. A., Unadkat, S., Hughes, J., Dwivedi, R., Forde, C. T., Randhawa, P., Gane, S., Joseph, J., Andrews, P. J., Royle, G., Franchi, A., Maragliano, R., Battocchio, S., Bewicke-Copley, H., Pipinikas, C., Webster, A., Thirlwell, C., Ho, D., Teschendorff, A., Zhu, T., Steele, C. D., Pillay, N., Vanhaesebroeck, B., Mohyeldin, A., Fernandez-Miranda, J., Park, K. W., Le, Q. T., West, R. B., Saade, R., Manes, R. P., Omay, S. B., Vining, E. M., Judson, B. L., Yarbrough, W. G., Sansovini, M., Silvia, N., Grassi, I., Bongiovanni, A., Capper, D., Schüller, U., Thavaraj, S., Sandison, A., Surda, P., Hopkins, C., Ferrari, M., Mattavelli, D., Rampinelli, V., Facchetti, F., Nicolai, P., Bossi, P., Henriquez, O. A., Magliocca, K., Solares, C. A., Wise, S. K., Llorente, J. L., Patel, Z. M., Nayak, J. V., Hwang, P. H., Lacy, P. D., Woods, R., O'Neill, J. P., Jay, A., Carnell, D., Forster, M. D., Ishii, M., London, N. R., Bell, D. M., Gallia, G. L., Castelnuovo, P., Severi, S., Lund, V. J., & Hanna, E. Y. (2021). Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. European journal of cancer (Oxford, England : 1990), . https://doi.org/10.1016/j.ejca.2021.09.046
Lechner, Matt, et al. "Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma." European journal of cancer (Oxford, England : 1990) vol. (2021). doi: https://doi.org/10.1016/j.ejca.2021.09.046
Lechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, Kaur RP, Zhao T, Ramanathan M, Schartinger VH, Emanuel O, Helman S, Varghese J, Dudas J, Riechelmann H, Sprung S, Haybaeck J, Howard D, Engel NW, Stewart S, Brooks L, Pickles JC, Jacques TS, Fenton TR, Williams L, Vaz FM, O'Flynn P, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Royle G, Franchi A, Maragliano R, Battocchio S, Bewicke-Copley H, Pipinikas C, Webster A, Thirlwell C, Ho D, Teschendorff A, Zhu T, Steele CD, Pillay N, Vanhaesebroeck B, Mohyeldin A, Fernandez-Miranda J, Park KW, Le QT, West RB, Saade R, Manes RP, Omay SB, Vining EM, Judson BL, Yarbrough WG, Sansovini M, Silvia N, Grassi I, Bongiovanni A, Capper D, Schüller U, Thavaraj S, Sandison A, Surda P, Hopkins C, Ferrari M, Mattavelli D, Rampinelli V, Facchetti F, Nicolai P, Bossi P, Henriquez OA, Magliocca K, Solares CA, Wise SK, Llorente JL, Patel ZM, Nayak JV, Hwang PH, Lacy PD, Woods R, O'Neill JP, Jay A, Carnell D, Forster MD, Ishii M, London NR, Bell DM, Gallia GL, Castelnuovo P, Severi S, Lund VJ, Hanna EY. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer. 2021 Dec 31; doi: 10.1016/j.ejca.2021.09.046. Epub 2021 Dec 31. PMID: 34980502.
Copy Download .nbib Format: NLM
ENT training amongst general practitioners: results from a questionnaire.

The Journal of laryngology and otology

Dimitrov L, Unadkat S, Khanna A, Rennie C, Saleh H.
PMID: 32054560
J Laryngol Otol. 2020 Feb 14;1-7. doi: 10.1017/S0022215120000201. Epub 2020 Feb 14.

OBJECTIVES: To evaluate the level of undergraduate and post-graduate ENT exposure amongst general practitioners and their perceived quality of this training. A secondary aim was to examine whether general practitioners believe ENT department based rotations should remain in the...

Cite
Dimitrov L, Unadkat S, Khanna A, et al. ENT training amongst general practitioners: results from a questionnaire. J Laryngol Otol. 2020;1-7doi: 10.1017/S0022215120000201.
Dimitrov, L., Unadkat, S., Khanna, A., Rennie, C., & Saleh, H. (2020). ENT training amongst general practitioners: results from a questionnaire. The Journal of laryngology and otology, 1-7. https://doi.org/10.1017/S0022215120000201
Dimitrov, L, et al. "ENT training amongst general practitioners: results from a questionnaire." The Journal of laryngology and otology vol. (2020): 1-7. doi: https://doi.org/10.1017/S0022215120000201
Dimitrov L, Unadkat S, Khanna A, Rennie C, Saleh H. ENT training amongst general practitioners: results from a questionnaire. J Laryngol Otol. 2020 Feb 14;1-7. doi: 10.1017/S0022215120000201. Epub 2020 Feb 14. PMID: 32054560.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries